Can we quantify the benefits of DMDs in multiple sclerosis?
Alan
A
Thompson
D004185:Disability Evaluation; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000503:physiopathology; D013995:Time
D007155:Immunologic Factors